NanoImprove Your Small And Large Molecule Formulations Across The Product Life Cycle

This cutting-edge technology significantly enhances the bioavailability of both small and large molecule formulations, offering a superior alternative to traditional amorphous solid dispersions (ASD). By leveraging the world's smallest nanoparticles, Nanoform facilitates improved solubility while reducing reliance on polymers or excipients, resulting in simpler, more cost-effective, and environmentally friendly formulations.

Nanoform's innovative approach is particularly advantageous for complex therapeutic areas, including oncology, biologics, and ophthalmics. The technology enables higher drug load capacities, reducing the pill burden and enhancing patient adherence, especially for pediatric, geriatric, and dysphagic populations. Furthermore, it supports tailored delivery profiles and optimized administration routes, from oral to injectable options, significantly improving patient convenience.

With proven efficacy demonstrated in various clinical studies, Nanoform is redefining drug delivery systems, achieving impressive results such as five times higher drug loads for glioblastoma treatments and over 95% fine particle fractions for respiratory applications. Discover the transformative potential of nanotechnology in drug formulation and delivery and how Nanoform's advanced capabilities can enhance your pharmaceutical products and extend their lifecycle.